CLINICAL_TRIALS
trial_result
· 2016-01-22
Clinical Trial Update: A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain [Phase 2]
Summary
A Phase 2 study evaluating the safety and effectiveness of JNJ-42160443 as add-on therapy for cancer-related pain has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Pain, Burning, Pain, Crushing | Phase 2 | Status: COMPLETED